These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26320383)

  • 1. Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study.
    Morales EE; Grill S; Svatek RS; Kaushik D; Thompson IM; Ankerst DP; Liss MA
    Eur Urol; 2016 Mar; 69(3):407-10. PubMed ID: 26320383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal manipulation with finasteride or oral contraception does not influence incidence of renal cell carcinoma.
    Kabra A; Gelfond J; Liss MA
    Eur J Cancer Prev; 2018 Sep; 27(5):449-452. PubMed ID: 28338531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finasteride does not prevent bladder cancer: A secondary analysis of the Medical Therapy for Prostatic Symptoms Study.
    Sathianathen NJ; Fan Y; Jarosek SL; Lawrentschuk NL; Konety BR
    Urol Oncol; 2018 Jul; 36(7):338.e13-338.e17. PubMed ID: 29731413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.
    Unger JM; Till C; Thompson IM; Tangen CM; Goodman PJ; Wright JD; Barlow WE; Ramsey SD; Minasian LM; Hershman DL
    J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27565902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finasteride Use and Risk of Bladder Cancer in a Multiethnic Population.
    Zhu D; Srivastava A; Agalliu I; Fram E; Kovac EZ; Aboumohamed A; Schoenberg MP; Sankin AI
    J Urol; 2021 Jul; 206(1):15-21. PubMed ID: 33617325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with finasteride and prostate cancer survival.
    Kjellman A; Friis S; Granath F; Gustafsson O; Sørensen HT; Akre O
    Scand J Urol; 2013 Aug; 47(4):265-71. PubMed ID: 23137166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Finasteride on Survival in Bladder Cancer: A Retrospective Multi-institutional Database Analysis.
    Garg H; Wheeler KM; Dursun F; Cooper RE; Pruthi DK; Kaushik D; Thompson IM; Svatek RS; Liss MA
    Clin Genitourin Cancer; 2023 Apr; 21(2):314.e1-314.e7. PubMed ID: 36402643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort.
    Krabbe LM; Svatek RS; Shariat SF; Messing E; Lotan Y
    Urol Oncol; 2015 Feb; 33(2):65.e19-25. PubMed ID: 25044253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childbearing and the risk of bladder cancer: a nationwide population-based cohort study.
    Weibull CE; Eloranta S; Altman D; Johansson AL; Lambe M
    Eur Urol; 2013 Apr; 63(4):733-8. PubMed ID: 23332884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of finasteride on the development of prostate cancer.
    Thompson IM; Goodman PJ; Tangen CM; Lucia MS; Miller GJ; Ford LG; Lieber MM; Cespedes RD; Atkins JN; Lippman SM; Carlin SM; Ryan A; Szczepanek CM; Crowley JJ; Coltman CA
    N Engl J Med; 2003 Jul; 349(3):215-24. PubMed ID: 12824459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors.
    Mäkelä VJ; Kotsar A; Tammela TLJ; Murtola TJ
    J Urol; 2018 Oct; 200(4):743-748. PubMed ID: 29730200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effects and economical impact of dutasteride and finasteride therapy in Italian men with LUTS.
    Cindolo L; Berardinelli F; Fanizza C; Romero M; Pirozzi L; Tamburro FR; Pellegrini F; Neri F; Pitrelli A; Schips L
    Arch Ital Urol Androl; 2013 Dec; 85(4):200-6. PubMed ID: 24399122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers.
    Bangma CH; Loeb S; Busstra M; Zhu X; El Bouazzaoui S; Refos J; Van Der Keur KA; Tjin S; Franken CG; van Leenders GJ; Zwarthoff EC; Roobol MJ
    Eur Urol; 2013 Jul; 64(1):41-7. PubMed ID: 23478169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
    Stanczyk FZ; Azen CG; Pike MC
    J Steroid Biochem Mol Biol; 2013 Nov; 138():10-6. PubMed ID: 23474436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis.
    Belknap SM; Aslam I; Kiguradze T; Temps WH; Yarnold PR; Cashy J; Brannigan RE; Micali G; Nardone B; West DP
    JAMA Dermatol; 2015 Jun; 151(6):600-6. PubMed ID: 25830296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-alpha reductase inhibitors (5-ARi) with or without alpha-blockers (α-B) for Benign Prostatic Hyperplasia do NOT lower the risk of incident Bladder Cancer: United States insurance claims data.
    Del Giudice F; Belladelli F; Glover F; Basran S; Li S; Mulloy E; Pradere B; Soria F; Krajewski W; Nair R; Muncey W; Seranio N; Eisenberg ML
    World J Urol; 2023 Oct; 41(10):2783-2791. PubMed ID: 37548746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis.
    Daugherty SE; Pfeiffer RM; Sigurdson AJ; Hayes RB; Leitzmann M; Schatzkin A; Hollenbeck AR; Silverman DT
    Am J Epidemiol; 2011 Apr; 173(7):721-30. PubMed ID: 21367875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Genomic Alterations of 5α-Reductases and Their Inhibitor Finasteride's Effect in Bladder Cancer.
    Chen CC; Huang CP; Tsai YT; Hseih TF; Shyr CR
    Anticancer Res; 2017 Dec; 37(12):6893-6898. PubMed ID: 29187470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative outcomes of primary, recurrent, and progressive high-risk non-muscle-invasive bladder cancer.
    Thomas F; Noon AP; Rubin N; Goepel JR; Catto JW
    Eur Urol; 2013 Jan; 63(1):145-54. PubMed ID: 22985746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finasteride.
    Chaudhary UB; Turner JS
    Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):873-81. PubMed ID: 20536414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.